Objective Prediabetes is a condition between a normal metabolic state and diabetes mellitus, which includes impaired glucose tolerance (IGT), impaired fasting glucose (IFG), or both. Prediabetes is related with undesirable cardiovascular outcomes. Epicardial fat thickness (EFT) has been correlated with cardiovascular risk factors. We herein aimed to assess EFT in prediabetic patients. Methods We evaluated 64 patients with prediabetes and 30 age-and gender-matched healthy subjects. Demographic and anthropometric characteristics [age, sex, height, weight, body mass index (BMI), and waist circumference (WC)] and laboratory findings [fasting plasma glucose (FPG), postprandial plasma glucose (PPG), hemoglobin A1c (HbA1c), low density lipoprotein (LDL), high density lipoprotein (HDL), and triglycerides (TG)] were assessed. Transthoracic echocardiography was used to evaluate EFT. Results There were no significant differences between the case and control groups in terms of age, gender, height, HDL, WC, systolic and diastolic blood pressure (SBP/DBP), or TG (p>0.05). Body weight, BMI, FPG, LDL, and, in particular, EFT were found to be significantly higher in the case group than control group (p<0.05). When compared with the control group, the median EFT was significantly higher in all prediabetic subgroups (IGT or IFG, p<0.001). However, no statistically significant difference was found between each case subgroup (p=0.795). When groups were adjusted according to age, sex, WC, and BMI with covariance test, the EFT remained increased in the prediabetes subgroups compared to the controls (p<0.001). Conclusion We found the EFT levels to be increased in all subgroups of prediabetic patients regardless of FPG and HbA1c. Furthermore, EFT directly correlated with the patients' BMI and WC.
Introduction
Worldwide, the number of individuals with diabetes mellitus (DM) is expected to double in the next 25 years and to affect more than 350 million individuals by 2030 (1) . Hence, there is an increasing interest in identifying individuals in stages preceding overt DM in order to potentially prevent the occurrence of DM and associated complications. The majority of complications of DM are related to cardiovascular disease. Therefore it is important to assess whether Epicardial fat is located on the heart surface between the myocardium and visceral layer of epicardium and surrounds the heart and epicardial coronary arteries. Epicardial fat thickness (EFT) plays an active role in the pathogenesis of atherothrombotic heart disease (6) . Adipocytes influence the myocardium and coronary arteries via cytokines and adipokines and act by paracrine and autocrine mechanisms. In previous studies, EFT was shown to correlate well with the degree of atherosclerosis in patients with coronary heart disease, hypertension, and metabolic syndrome (MS) and was suggested to be a predictive marker for early atherosclerotic changes, similar to carotid intima media thickness (7) . In the Framingham offspring cohort, EFT was found to correlate with male sex and age (8, 9) . There are reports in the literature studying various biochemical markers and carotid intima-media thickness for risk identification in prediabetic groups (10, 11) ; however, to the best of our knowledge, no reports have so far studied the correlation between EFT and other risk parameters in patients with prediabetes.
There are several ways of measuring EFT such as transthoracic echocardiography (TTE), magnetic resonance imaging (MRI), and multi-slice computed tomography (CT). Among those techniques, TTE is the simplest method which is easily applicable, reproducible, inexpensive, and does not expose patients to radiation (12) .
In the present study, we aimed to evaluate EFT in patients with prediabetes compared with age-and gender-matched healthy control subjects. We also sought to determine if EFT correlated with other cardiometabolic risk factors. To the best of our knowledge, this is the first study comparing EFT in different prediabetes subgroups (IFG and IGT) to control subjects with normal glucose tolerance.
Material and Methods
The present study was conducted at the Endocrinology Department of Yildirim Beyazit University, Ataturk Education and Research Hospital, Ankara, Turkey between December 2012 and June 2013. Sixty-four prediabetic individuals (24 male and 40 female, aged 27-70 years) and 30 age-and gender-matched control subjects were enrolled. The local Ethics Committee approved the study, and informed consent was obtained from each participant before the study commenced. The exclusion criteria were a known history of diabetes, ischemic heart disease, cerebrovascular disease, peripheral vascular disease, congestive heart failure, valvular heart disease, or chronic kidney disease.
Glucose tolerance and metabolism were evaluated using a 75 g OGTT. After an overnight fast of 12 hours, all subjects underwent an OGTT (a load of 75 g glucose in 300 mL water). Blood samples for the glucose measurements were drawn before the OGTT and 120 minutes thereafter. Glucose tolerance categories were defined according to the 2006 WHO criteria. IFG was defined as a FPG level of 100-125 mg/dL, whereas IGT was defined as a 120 minute plasma glucose level of 140-199 mg/dL during the OGTT. Prediabetic patients were subdivided into two subgroups. Patients with IFG were defined as Group I and those with IGT as Group II (patients who had IGT+IFG were excluded from the subgroup analysis). Venous blood samples were drawn in the morning, using vacutainer tubes for laboratory determinations. Plasma glucose, triglycerides (TG), total and high-density lipoproteins (HDL), and cholesterol concentrations were measured using enzymatic assays (Roche Diagnostics GmbH, Mannheim, Germany).
Subjects underwent anthropometrical evaluation. Height was measured in centimeters (cm), weight in kilograms (kg), and body mass index (BMI) was calculated as the weight in kg divided by height squared in metres (kg/m 2 ). Waist circumference was measured at the umbilical level.
Each patient underwent a complete TTE using the American Society of Echocardiography guidelines (13) . An experienced cardiologist, who was blinded to the patient's clinical information, performed all examinations. Echocardiography was performed using phased-array echocardiograms in Mmode, 2D, and pulsed and color-flow Doppler settings with 3.5-MHz transducers in the left lateral decubitus position. EFT was identified as the echo-free space between the outer wall of the myocardium and the visceral layer of the pericardium, and its thickness was measured on the free wall of the right ventricle from the parasternal long and short axis views. The ejection fraction was determined using the biplane Simpson formula.
Statistical analysis
Data analyses were performed using SPSS for Windows, version 11.5 (SPSS, Chicago, USA). The normal distribution of continuous variables was assessed using the Kolmogorov Smirnov test. Levene's test was applied to assess the homogeneity of variances. Continuous variables are presented as means ± standard deviation (SD) or medians (range), as appropriate. The differences between the means of the case and control groups were compared using Student's t-tests, and the Mann Whitney U test was used to compare median values. When the number of independent groups was more than two, one-way analysis of variance (ANOVA) and the Kruskal-Wallis test were used to compare the mean differences and median values among groups, respectively. When the p values obtained from the Kruskal-Wallis tests were significant, Conover's non-parametric multiple comparison tests were used to determine which groups differed. Nominal data were analyzed using Pearson's chi-squared tests. The degrees of association between continuous variables were evaluated using Spearman's rank correlation tests. Analysis of covariance (ANCOVA) tests were used after adjusting for age, gender, smoking history, blood pressures, waist circumference (WC), and BMI to assess whether statistically significant differences in EFT between the control and case groups persisted. Logarithmic transformations were applied to EFT data in the ANCOVA tests because of their non-normal distribution. All results are presented as adjusted EFT volumes after anti-log transformation. A p value <0.05 
<0.001
c was considered to be statistically significant.
Results
In this study, we evaluated 64 subjects in the case group and 30 subjects in the control group. Patient demographics, anthropometric characteristics, and clinical and laboratory features are shown in Table 1 . No significant differences were detected between the case and control groups with regards to age, gender, WC, systolic and diastolic blood pressures, HDL-C, TG levels, or height (p>0.05). The mean weight and BMI were significantly higher in the case group compared with the control group (p=0.013 and p=0.043, respectively). FPG, low density lipoprotein cholesterol (LDL-C) and EFT were also significantly higher in the case group compared with the control group (p<0.001, p=0.009, and p< 0.001, respectively; Table 1 ).
In the subgroup analysis, the mean body weight was significantly lower in the control group compared with the prediabetic subgroups (p=0.034). The median FPG level was significantly higher in Group I compared with Group II and the control group (p<0.05). The median EFTs were similar in the prediabetic subgroups but significantly higher than the control group (p<0.05). All other parameters were similar between the groups (Table 2) .
We also assessed whether the statistically significant difference in EFT between the prediabetic and control subjects remained when the groups were adjusted according to age, gender, smoking history, blood pressures, WC, and BMI using ANCOVA tests. EFT remained higher in the prediabetic case group compared with the control group (p<0.001; Fig. 1 ) after the adjustment. The corrected EFT in the control group was 2.70 (95% confidence interval (CI): 2.53-2.89) compared with 3.49 (95% CI: 3.34-3.65) in the case group (Fig. 1) .
The data revealed that EFT had positive correlations with WC and BMI. However, no other correlation was found between EFT and the other cardiovascular risk factors (Ta- We assessed whether statistically significant differences in EFT between the prediabetic subgroups and the control group remained after adjustments were made for age, gender, WC, and BMI by ANCOVA test. EFT remained higher in each prediabetes subgroup compared with the control group (p<0.001) after adjustment. The corrected EFT values in Group I, II, and the control group were 3.47 (95% CI: 3.24-3.71), 3.50 (95% CI: 3.23-3.80), and 2.70 (95% CI: 2.57-2.93), respectively. There was no difference between the prediabetes subgroups in terms of EFT (p>0.05; Fig. 2 ).
Discussion
Prediabetes is a clinical condition that is between a normal metabolic state and diabetes, and its prevalance is variable amongst different ethnic groups (14). In our country, the prevalance of IFG is 14%, IGT 7%, and . The incidence of developing diabetes each year is 4-6% for isolated IGT whereas it is 6-9% and 15-19% for IFG and IFG+IGT, respectively (16) . Prediabetes is also reported to be associated with other major risk factors (e.g., hypertension and dyslipidemia) of atherosclerosis (17, 18) . According to population-based studies, the development of macrovascular complications and mortality are increased in prediabetic populations (19, 20) . FPG, postprandial plasma glucose (PPG) and HbA1c are associated with increased mortality regardless of obesity, hypertension, and lipid profile (18, 21) . Microvascular complications, especially autonomic neuropathy, are also seen in prediabetics and results in increased mortality (22).
The contribution of impaired glucose metabolism to atherosclerosis and its relationship with EFT has become a popular subject of research in recent years. The role of EFT in the pathogenesis of vascular disease is not well understood, but it is suggested that vasoactive peptides and cytokines produced by epicardial fat tissue increases cardiovascular risk (23, 24) .
In previous reports, EFT was determined to significantly correlate with FPG, insulin resistance, hypertension, obesity, MS, diabetes, and coronary artery disease (25-30). EFT is an independent risk factor for adverse cardiac events (7, (31) (32) (33) . Moreover, EFT also correlated with peripheral vascular thickening and increased carotid intimamedia thickness (7, 34, 35) . In a previous report, EFT was suggested as a tool to assess cardiac risk in the screening of asymptomatic individuals (36, 37) .
Akyol et al. suggested that EFT correlated with insulin resistance and the homeostatis model assessment of insulin resistance (HOMA-IR) index. Furthermore, they suggested that EFT may be a better indicator of visceral obesity and could replace WC as a criteria in the diagnosis of MS (38) . In another report, patients with type 1 diabetes had more epicardial fat compared to the controls, and epicardial fat was related to central obesity and MS (39) . In the present study, EFT positively correlated with two components of MS: BMI and WC. In a recent study, in accordance with our data, a positive correlation was observed between EFT and visceral adipose tissue, WC, BMI, and insulin resistance in postmenopausal women (40) . In a meta-analysis of 38 studies, the relationship between EFT and generalized obesity, central or visceral adipose tissue, and components of MS linked to coronary artery disease (CAD) [such as systolic blood pressure (SBP), TGs, HDL-C, and FPG] was examined. There was a highly significant correlation (p<0.001) between EFT and BMI and WC. Contrary to our study, EFT correlated significantly with SBP, TGs, HDL, and FPG, but the strength of the association was less than one-half of the relationship of EFT to indices of obesity (41) . Another study showed that overweight men had increased EFT compared to the controls, and after a three month program of diet and biweekly exercise, EFT was significantly reduced in individuals who completed the weight-loss program (42) . Furthermore, another report showed differences in cardiovascular disease indices between patients who underwent either gastric bypass surgery or sleeve gastrectomy. In the echocardiographic evaluation, all parameters improved significantly at 6 months in comparison with the baseline values, including EFT (p=0.007) (43) .
In previous reports, the mean EFT of individuals with IFG was reported to be higher than individuals with normal glucose metabolism. Our study supports the current literature and shows that EFT is higher in all prediabetes subgroups than in the controls (44) .
Versteylen et al. also reported similar results and found that EFT was higher in patients with IFG compared to the controls; the authors concluded that EFT may be a beneficial marker for detecting subclinical coronary disease (31). Furthermore, in a previous study, PPG was also found to correlate with EFT in patients with type 2 diabetes (45) . To the best of our knowledge, this is the first study evaluating EFT in patients with IGT which determined that EFT is increased despite normal FPG levels in this group.
No differences were seen between groups with IFG, IGT, or both in terms of EFT. EFT was positively correlated with BMI and WC but not with FPG level or HbA1c, which is similar to a previous report (44) . However, contrary to a previous report, EFT was not correlated with the TG, LDL, or HDL levels in our study (46) .
There are conflicting studies regarding the correlation between EFT and age or gender. Our study results support the data shown by Iacobellis et al. and shows that EFT does not significantly change with increased age or vary according to gender (26). However, in the Framingham cohort, EFT positively correlated with age and gender (8) .
One limitation of this study is the small number of patients enrolled in the case and control groups, particularly in the control group. Further studies using larger sample sizes are necessary to elucidate the correlation of different metabolic parameters with EFT in glucose metabolism disorders.
In conclusion, EFT was increased in all prediabetic subgroups regardless of FPG and HbA1c. Therefore, lifestyle changes, such as weight loss, will not only reduce the patient's weight and WC but also eliminate other major risk factors for cardiac mortality.
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